This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
ALCL
and you are
-
The phase for this study is not defined.
Show me locations

The purpose

To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.

Provided treatments

  • Other: Blood sample

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02902874. The sponsor of the trial is Gustave Roussy, Cancer Campus, Grand Paris and it is looking for 250 volunteers for the current phase.
Official trial title:
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +